NDC 70518-3869-07 - DOXYCYCLINE HYCLATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-3869
- Requested NDC
- 70518-3869-07
- Package NDCs from labels
- 70518-3869-0, 70518-3869-1, 70518-3869-2, 70518-3869-3, 70518-3869-4, 70518-3869-5, 70518-3869-6, 70518-3869-7, 70518-3869-8, 70518-3869-9, 70518-3869-07
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DOXYCYCLINE HYCLATE TABLETS, USP | REMEDYREPACK INC. | 2026-09-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-3869-0 | DOXYCYCLINE HYCLATE | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | 13 | |
| 70518-3869-1 | DOXYCYCLINE HYCLATE | 10 in 1 BOTTLE, PLASTIC | TABLET | 10 | 13 | |
| 70518-3869-2 | DOXYCYCLINE HYCLATE | 14 in 1 BOTTLE, PLASTIC | TABLET | 14 | 13 | |
| 70518-3869-3 | DOXYCYCLINE HYCLATE | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 13 | |
| 70518-3869-4 | DOXYCYCLINE HYCLATE | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 13 | |
| 70518-3869-5 | DOXYCYCLINE HYCLATE | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 13 | |
| 70518-3869-6 | DOXYCYCLINE HYCLATE | 28 in 1 BOTTLE, PLASTIC | TABLET | 28 | 13 | |
| 70518-3869-7 | DOXYCYCLINE HYCLATE | 50 in 1 BOTTLE, PLASTIC | TABLET | 50 | 13 | |
| 70518-3869-8 | DOXYCYCLINE HYCLATE | 56 in 1 BOTTLE, PLASTIC | TABLET | 56 | 13 | |
| 70518-3869-9 | DOXYCYCLINE HYCLATE | 30 in 1 BLISTER PACK | TABLET | 30 | 13 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-3869 | DOXYCYCLINE HYCLATE TABLET [REMEDYREPACK INC.] | 6 | Current NDC, 10 package rows | 20250423_5fdc01c3-c62f-40cf-8351-91cbcc43d379.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxycycline | DOXYCYCLINE | Avenacy Inc. | 429813b4-0223-4d85-a844-b1227ff63b1e | 2026-08-06 | Warnings, Adverse reactions | 19XTS3T51U |
| Calamine | FERRIC OXIDE RED | The Kroger Co. | 9ddcd6ba-1aed-48f8-a91a-54bd6f0d9308 | 2026-08-06 | Warnings, Adverse reactions | 1K09F3G675 |
| EltaMD UV Restore | TITANIUM DIOXIDE, ZINC OXIDE SUNSCREEN | CP Skin Health Group, Inc | 37fee381-ce6b-4949-9a4a-778aa839fb84 | 2026-08-06 | Warnings | 15FIX9V2JP |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | Major Pharmaceuticals | e7c14a8e-c713-4f03-94e8-1ec9ae077d4d | 2026-08-05 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Doxycycline Hyclate | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | 2305ab4a-7d08-41f6-9c39-c9b6835be389 | 2026-08-05 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| Leader Lubricant Eye Drops 30ct | POLYETHYLENE GLYCOL 400, PROPYLENE GLYCOL | CARDINAL HEALTH 110, LLC. DBA LEADER | 8df69f2c-40c4-245c-e053-2a95a90a5406 | 2026-08-05 | Warnings | B697894SGQ |
| ROROBELL WAWA Whitening Tooth | SILICA, HYDROGEN PEROXIDE, TOCOPHERYL ACETATE | ROROBELL | 58336a0d-49dd-ef13-e063-6394a90a38c1 | 2026-08-04 | Warnings | ETJ7Z6XBU4 |
| Silicea 6X | SILICON DIOXIDE | Hyland's Inc. | db4be3c1-aa7e-24a2-e053-2a95a90a0c66 | 2026-08-04 | Warnings | ETJ7Z6XBU4 |
| doxycycline | DOXYCYCLINE | A-S Medication Solutions | fe8cd3c6-36d6-4d92-bc5c-833cd6f9cb32 | 2026-08-04 | Warnings, Adverse reactions | 19XTS3T51U |
| Luxe Gloss Hydrating Lip Gloss SPF 35-NAKED HONEY | OCTOCRYLENE 8%, OCTISALATE 5%, TITANIUM DIOXIDE 6%, ZINC OXIDE 8% | Lale Cosmetics LLC | 581fb0cd-c55d-d562-e063-6394a90a7f11 | 2026-08-03 | Warnings | 15FIX9V2JP |
| Doxycycline | DOXYCYCLINE HYCLATE | REMEDYREPACK INC. | db53637e-16ac-41b0-b9d5-553471405d64 | 2026-08-03 | Warnings, Adverse reactions | 1650143 19XTS3T51U |
| DOXYCYCLINE | DOXYCYCLINE | Lupin Pharmaceuticals, Inc. | 2946fc05-78e5-4669-85d1-3a3979eceae0 | 2026-08-03 | Warnings, Adverse reactions | 19XTS3T51U |
| EltaMD UV Active | ZINC OXIDE AND TITANIUM DIOXIDE SUNSCREEN | CP Skin Health Group, Inc | 39d16479-d491-4c19-aa11-674461687c7b | 2026-08-03 | Warnings | 15FIX9V2JP |
| Continuous Correction Cream | TITANIUM DIOXIDE | Baxter of California, LLC | 1cbcc648-f2e1-af60-e063-6294a90ad4bb | 2026-07-31 | Warnings | 15FIX9V2JP |
| Cover Creme | TITANIUM DIOXIDE | Baxter of California | 31f5e8c4-523f-4596-e063-6294a90a6a12 | 2026-07-31 | Warnings | 15FIX9V2JP |
| Smogstat | ECHINACEA (ANGUSTIFOLIA), HYPERICUM PERFORATUM, HYDRASTIS CANADENSIS, SYMPHYTUM OFFICINALE, ARSENICUM ALBUM, CARBO VEGETABILIS, CAUSTICUM, KALI CARBONICUM, NATRUM SULPHURICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SILICEA | Energique, Inc. | 59f63e2b-24fa-43a0-8334-02e6729c6ac1 | 2026-07-31 | Warnings | ETJ7Z6XBU4 |
| Garzulys | INSULIN ASPART-FSAN | Meitheal Pharmaceuticals Inc. | 30c64769-d2f7-4604-ac9e-2a6bc09506c9 | 2026-07-31 | Warnings, Adverse reactions | 059QF0KO0R |
| Muscle Ice | PHYTOLACCA DECANDRA, BELLIS PERENNIS, LEDUM PALUSTRE, RUTA GRAVEOLENS, SYMPHYTUM OFFICINALE, MAGNESIA PHOSPHORICA, SILICEA, MENTHOL (CRYSTALS) | Peaceful Mountain, Inc. | 03b6e2a9-f335-4ae2-9011-80bd019afb72 | 2026-07-30 | Warnings | ETJ7Z6XBU4 |
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | ETJ7Z6XBU4 |
| doxycycline | DOXYCYCLINE | Preferred Pharmaceuticals Inc. | bcc95094-80ed-4023-b2a6-955a4810bfbe | 2026-07-30 | Warnings, Adverse reactions | 19XTS3T51U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.